Bruce Salzberg
Atlanta Gastroenterology Associates(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Chronic Lymphocytic Leukemia Research, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease(2016)1,764 cited
- → Celecoxib for the Prevention of Sporadic Colorectal Adenomas(2006)1,036 cited
- → Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry(2006)906 cited
- → Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry(2012)785 cited
- → Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease(2002)222 cited
- → Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease(1999)205 cited
- → Factors Associated with the Development of Intestinal Strictures or Obstructions in Patients with Crohn's Disease(2006)203 cited
- → Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial(2017)197 cited
- → Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial(2009)193 cited
- → Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis(2002)177 cited